TP53 and B-cell chronic lymphocytic leukemia: In a previous study, Griggio et al96 found that leukemia cells of CLL patient origin with TP53 (tumor suppressor gene) deficiency have higher expression and transcriptional activity of HIF-1α, which contributes to tumor progression, and therefore this group of patients is exposed to a worse prognosis.